El síndrome preeclampsia - eclampsia

Sibai BM., Taslimi M et al. Maternal and perinatal outcome of conservati ve management of severe preclampsia in midtrimester. Am. J. Obstet. Gynecol. 1985 ; 152: 32-37.

Sibai BM. Preeclampsia-eclampsia. Curr. Probl. Obstet. Gynecol. Fertil, Jan/Feb 1990; 1-45.

Gant NF. , Worley RJ. Hipertensión en el embarazo, conceptos y tratamiento. México D.F. Ed. El Manual Moderno S.A., 1982 .

OMS. Trastornos hipertensivos del embarazo. Serie de informes técnicos, 1987 ; 758 (8) .

Zuspan FP. The hipertensive disorders of pregnancy: Report o f a WHO Study Group. Technical report series, 1987 , WHO, Geneva, No. 758.

Zuspan FP. New concept s in the understanding of hypertensive diseases during pregnancy. An overview. Clin in perinatol 1991 ; 18(4): 72-80.

Lindheimer MD., Katz AI. Preeclampsia. pathophysiology, diagnosis and manage ment. Ann. Rev . Med. 1989; 40: 233-250.

Pritchard JA ., Mac Donald PC. , Gant NF. Hypertension in pregnancy. In Williams Obstetrics. 17th ed, Norwalk Connecticut , 1985. Appleton-Century-Crofts.

Coodlin CR. Expanded toxemia syndrome or gestosis. Am. J. Obstet. Gynecol. 1986; 154: 151.

Villar MA., Sibai BM. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or distolic blood pressure during third trimester. Am. J. Obstet. Gynecol. 1989; 160: 419-423.

Lindheimer MD. , Katz Al. Hypertension in pregnancy. New Engl. J. Med. 1985; 313: 675-680.

Doan-Wiggin s L. Hypertensive disorders in pregnancy. Emergency Med. Clin. North. Am. 1987; 5(3): 723-734.

Chesley LC. Hypertension in pregnancy: definitions, familiar factors and remote prognosis. Kidney International 1980; 18: 234-240.

Gleicher N. , Boler LR. , Norusis M et al. Hypertensive diseases of pregnancy and parity . Am. J. Obstet. Gynecol. 1986; 154: 1044- 1049.

Sibai BM. Eclampsia : I. Observations from recent 67 cases Obstet. Gynecol. 198 1; 58: 609-6 13.

Sibai BM. Chronic hypertension in pregnancy. In Hypertension and pregnancy, Clin in perinatol 1991; 18:4.

Calero R. Enfermedad vascular hipertensiva crónica Memorias del curso : Complicaciones médicas en el embarazo, Experiencia Institucional IMI. Bogotá, noviembre 11-12, 1988.

Mabie WC. , Pernoll ML., Biswas MK. Chronic hypertension in pregnancy. Obstet. Gynecol. 1986; 67: 197-205.

Sibai BM. Chronic hypertension during pregnancy. In Sciarra Gynecology and Obstetrics, Philadelphia, Ed. JB Lippincott Co, 1989; 2(30): 1-8.

Gant NF., Daley GL., Chand S. A study of angiotensin JI pressor response throughout primigravid pregnancy. J. Clin. In vest. 1973; 52: 2684.

Gant NF., Whalley P et al. A prospective study of angiotensin II pressor responsiveness in pregnancies complicated by chronic essential hypertension. Am. J. Obstet. Gynecol. 1977; 127: 369.

St Louis J., Sicotte B. Prostaglandin -or endothelium- mediated vasodilation is not involvedin the blunted responses of blood vessels to vasoconstrictors in pregnant rat s. Am. J. Obstet. Gynecol. 1992; 166: 684-692.

Romero R., Lockwood CH. , Oyarzun E. Toxemia: New concepts of and old disease. Sem in perinatol 1988; 12(4): 302-323.

Hodari AA. Chronic uterine ischemia and reversible experimental «toxemia of pregnancy>>. Am. J. Obstet. Gynecol. 1967; 97: 597-607

Robertson WP .. Khong TY., Brosens lA. The placenta! bed bopsy: Review for three european centers. Am. J. Obstet. Gynecol. 1986; 155: 401.

Brosens IA. Morphological changes in the utero placental bed in pregnancy hypertension. Clin Obstet. Gynecol. 1977; 4: 583-593.

Shanklin DR., Sibai BM. Ultra estructural aspects of preeclampsia. Placental bed and uterine boundary vessels. Am. J. Obstet. Gynecol. 1989; 16 1: 735-741.

De Jong CL. , Dekker GA., Sibai BM. The reninangiotensinaldosterone system in preeclampsia . A review. Clin Perinatol 1991 ; 18(4): 683-711.

Krege JH., Katz Y L. A proposed relationship between vasopressinase altered vasopress in and preeclampsia. Med Hypotheses 1990; 31 (4): 283-287.

Friedmann SA., Taylor RN., Robert s JM. Pathophysiology of preeclampsia. En Hypertension and pregnancy. Clin in perinatol 1991 ;18(4): 661-682.

Miyamoto S., Shimokawa H., Sumioki H. , Touno A., Nakuno H. Circadian rhythm of plasma atrial natriuretic peptide, aldosterone and blood pressure during the third trimester in normal and preeclamptic pregnancies. Am. J. Obste t. Gynecol. 1988; 158:393.

Thaumau GR. The preeclampsia-eclampsia syndrome . En Obstetrics, Gynecology and Fertility Year Book. Medical Publishers, INC, 1985; 8: 24.

Weir RJ ., Frase R., Levr AF et al. Pl asma in hypertensive disease of pregnancy. Lancet 1973; 1: 191.

Laragh JH. Atri al natriuretic hormone, the renine angiotensin axis and blood pressure during the third trimester in normal and preeclamptic pregnancies. Am. J. Obstet. Gynecol. 1985; 313: 1330.

Symonds EM. The placenta and the renin-angiotensin system. J.Reprod . Med. 1979; 23: 129-1 33.

Tsukimori K., Maeda H et al. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet. Gynecol. 1992; 80: 229-233.

Rodríguez KA. La adaptación cardiovascular al embarazo. RCC (en curso de impresión).

Raffert y TD., Berkowitz RL. Hemodynamics in patients with severe toxemia during labor and delivery. Am. J. Obstet. Gynecol. 1980; 138: 263-270.

Easterling TR., Benedetti TJ. , Schmucker BC et al. Maternal hemodynamics in normal and preeclamptic pregnancies : a longitudinal study. Obstet. Gynecol. 1990; 76: 1061-1069.

Chesley LC. Plasma and red cell volumes during pregnancy. Am. J. Obstet. Gynecol. 1972; 11 2:440-448.

Sibai BM., Anderson GD., Spinnato JA et al. Plasma volume findings in patients with mild pregnancy induced hypertension. A m. J. Obstet. Gynecol. 1983; 147: 16-19.

Buchan PC. Preeclampsia: A hyperviscosity syndrome. Am. J. Obstet. Gynecol. 1982; 142: 111-112.

Phelan JP., Yurth DA. Severe preeclampsia. Peripartum hemodynamic observations. Am. J. Obstet. Gynecol. 1982; 144: 17-22.

Vane JR., Angaard MD., Botting RM. Regulatory functions of the vascular endothelium. New. Engl. J. Med. 1990; 323(1): 27-36.

Ferris TF. Pregnancy, preeclampsia and the endothelial cell. New. Engl. J. Med. 199 1; 325(20): 1439- 1440.

Yanagisawa M., Kurihara H., Kimura S et al. A novel potent vasoconstrictor peptide produced by vasculoepithelial cells. Nature 1988; 332: 4 11 -41 5.

Endothelins (Editorial ): The Lancet 199 1, 337 (Jan 12): 79-80.

Schiff E., Ben-Baruch G., Peleg E et al. Inmunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am. J. Obstet. Gynecol. 1992; 166: 624-628.

Kamoi K., Sudo N et al. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N. Engl. J. Med. 1990; 323: 1486- 1487.

Ballegeer VC., Spitz B., De Baene LA et al. Platelet activation and vascular damage in gestational hypertension. Am. J. Obstet. Gynecol. 1992; 166: 629-633.

Ignarro LJ. Byosinthesis and metabolism of endothelium derived nitric oxide. Ann. Rev. Pharmacol Toxicol 1990; 30: 333.

Myatt L. , Brewer AS et al. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal placental circulation. Am. J. Obstet. Gynecol. 1992; 166: 224-230.

Gerlach H., Esposito C., Stern DM. Modulation of endot belial hemostatic properties. An active role in the host response. Ann Rev Med 1990; 41: 15.

Newby AC., HendersonAH. Stymulous-secretion couplin in vascular endothelial cells. Ann. Rev. Physiol. 1990; 52: 66 1.

Everett RB., Worlcy RJ et al. Oral administration of theophy line to modify pressor response to angiotensin II in women with pregnancy induced hypertension. Am. J. Obstet. Gynecol. 1978; 132: 359-363.

Moncada S., Palmer RM., Higgs EA. Prostacyclin and endothelium derived relaxing factor: Biologycal interactions and significance. Thrombosis and haemostasis. International Society on Thrombosis and Haemostasis. Leuven University Press, 1987.

Friedmann SA. Preeclampsia: A review of the role of postaglandins. Obstet. Gynecol. 1988; 7 1: 122-1 37.

Fitgerald DJ., Entmann SS et al. Decreased prostaglandin biosynthesis preceding the clinical manifestations of pregnancy- induced hypertension. Circulation 1987; 75: 956-963.

Pinto A., Sorrentino R., Sorrentino P et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am. J. Obstet. Gynecol. 1991; 164: 507-513.

Chang J K., Roman C. , Heyman n MA. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am. J. Obstet. Gynecol. 1992; 166: 727-734.

Weiner CP. , Thompson LP et al. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am. J. Obstet. Gynecol. 1992; 166: 1171-1181.

Molnar M., Hertelendy F. Nw-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am. J. Obstet. Gynecol. 1992; 166: 1560-1567.

Khong TY., Sawyer IH., Heryet AR. An inmunohistologic study of endothelialization of utero placental vessels in human pregnancy evidence that endothelium is focally disrupted by trophoblast in preeclampsia. Am J. Obstet. Gynecol. 1992; 167: 751 -756.

Phelps SJ., Cochran EB., Gonzalez-Ruiz A et al. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like inmunoreactive substance. Am. J. Obstet. Gynecol. 1988; 158: 34-39.

Hirai N., Yanalhara T et al. Plasma levels of atrial natriuretic peptide during normal pregnancy and in pregnancy complicated by hypertension. Am. J . Obstet. Gynecol. 1988; 159:27-31.

Castro C., K ato Y., Braunstein D. Secretion of atrial natriuretic factor by cytotrophoblast in vitro. En Society for gynecologic investigation, 36 th meeting, San Diego, California, 1989; 188.

Atrial natriuretic factor: structure and functional properties. Kidney Int. 1985; 27: 607-61 5.

Laragh JH . Atrial natriuretic hormone, the renin aldosterone axis and blood pressure-electrolyte homeostasis. New. Engl. J. Med. 1985; 31 3: 1330-1340.

Rutherford AJ., Anderson JV ., Elder MG., Bloom SR. Release if atrial natriuretic peptide during pregnancy and inmediate puerperium. Lancet, 1987, April 18: 308.

Redman CW., Abbington MJ., Bott o n PG et al. Plasma betathromboglobulin in preeclampsia. Lancet 1977; 2: 248-250.

Saleh AA., Bottoms SF., Gant NF et al. Hemostasis in hypertensive disorders in pregnancy. Obstet. Gynecol. 1988; 71: 71 9-722.

Lazarchick J., Stubbs TM et al. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am. J. Obstet. Gynecol. 1986; 154: 1050-1052.

Weiner CP., Brandt J. Plasma antithrombin activity and aid to the diagnosis in preeclampsia. Am. J. Obstet. Gynecol. 1982; 142: 275-

Rappaport Y J., Hirata G ., Yak HK et al. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am. J. Obstet. Gynecol. 1990; 162: 138-146.

Puffer WH., Cheek ES. , Oakes KG et al. Vasoactive effect of sera from preeclamptic patients. A m. J. Obstet. Gynecol. 1982; 142:468.

Rodgers GM., Taylor RN., Robert s J M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am. J. Obstet. Gynecol. 1988; 159: 908.

Omar HA. , Figueroa R. , Omar RA el al. Hydrogen peroxide and reoxygenation cause prostaglandin-mediated contraction of human placental arteries and veins. Am. J. Obstet. Gynecol. 1992; 167:20 1- 207.

Sorokin G., Grant NM., Egan BM., Lombard JH. Cyclooxigenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries. Am. J. Obstet. Gynecol. 1992; 167: 110- 114.

Tsukimori K .. Maeda H .. Shingu M et al. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet. Gynecol. 1992; 80: 229-233.

Davidge ST., Hubel CA., Brayden RD et al. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet. Gynecol. 1992; 79: 897-901.

Bardeguez AD., Mc Nerney R., Frieri M et al. Cellular inmunity in preeclampsia: alterátions in T-lymphocite subpopulations during early pregnancy. Obstet. Gynecol. 1991; 77: 859-862.

Sibai BM. Inmunologic aspects of preeclampsia. En Inmunologic disturbances in pregnancy. Clin . Obstet. Gynecol. 1991; 34(1): 27-34.

The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Ann. Intern. Med. 1988; 148(5): 1023- 1038.

Kunt WD. Supine preesor (roll-over) test: an evaluation. Am. J. Obstet. Gynecol. 1980; 137: 764-768.

Arias F. Hypertension during pregnancy. En High Risk Pregnancy and Delivery . St Louis, 1984. the Cv Mosby Co. 6:9 1-1 20.

Amarís O., Guzmán F., Vargas F y cols. Fórmulas y definicioes en cuidado crítico. En Cardiología del adulto-revisión de ternas. RCC 1990; 3: 219.

Ales KL., Norton ME., Druzin ML. Early prediction of antepartum hypertension. Obstet. Gynecol. 1989; 73: 928.

Pickering TG. Clinical applications of ambulatory blood pressure monitoring: The white coat syndrome. Clin. Invest. Med. 1991; 14: 212.

Reiss RE., O' shaughnessy RW, Quilligan ET., Zuspan PP. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Arn. J. Obstet. Gynecol. 1987; 156: 894-898.

Villar J., Repke J et al. The measuring of blood pressure during pregnancy. Arn. J. Obstet. Gynecol. 1989; 161: 1019-1024.

Johenning AR., Barren WM. Indirect blood pressure measurement in pregnancy: Korotkoff phase 4 versus phase 5. Am. J. Obstet. Gynecol. 1992; 167: 577-580.

Lindheirner MD., Katz AL The renal response to pregnancy. The Kidney, 1981, Brenner and Rector Ed. WB Sanders Co. 33: 1762.

Balcells A. La Clínica y el Laboratorio. Barcelona, 1981, Ed. Marín S.A. 1: 17-19.

Boler L., Zbella EA. Quantitation of proteinuria in pregnancy by the use of single voided urine sample. Obstet. Gynecol. 1987; 70: 99- 100.

Sibai BM. Preeclampsia-Eclampsia: Clinical Obstetrics. En Sciarra Gynecology and Obstetrics, Philadelphia, 1988, JB Lippincott Co. 2: 4.

Sibai BM., Tashimi M et al. Matenal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzimes and low platelets in preeclampsia-eclampsia. Arn. J. Obstet. Gynecol. 1986; 155 : 501.

Gilstrap LC., Cunningham FG., Walley PJ. Management of pregnancy induced hypertension in the nulliparous patient remote from term. Sem Perinatol 1978; 2: 73.

Rodríguez KA. Crisis Hipertensivas. En Cardiología del Adulto- Revisión de Temas, RCC 1988; 2(6): 449-455.

Redman CW., Beilin LJ., Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br. J. Obstet. Gynecol. 1977; 84: 419.

Rubin PC., Butters L., Low RA., Reid JL. Clinical pharmacological studies with prazocin during pregnancy complicated by hypertension. Br. J. Clin. Pharrnacol. 1983; 16: 543.

Sandstrom B. Antihypertensive treatment with metoprolol in pregnancy. Gynecol. Obstet. Invest. 1978; 9: 125-204.

Pickles CJ., Symonds EM., Pipkin FB. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertensión. Br. J. Obstet. Gynecol. 1989; 96: 38-43.

Plouin PP., Breart FM et al. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br. J. Obstet. Gynecol. 1988; 95: 868-876.

Fenakel K., Fenakel G., Appelman Z et al. Nifedipine in the treatment of severe preeclampsia. Obstet. Gynecol. 1991; 77(3): 331-337.

Rogers RC., Sibai BM.; Whybrew D. Labetalol pharmacokinetics in pregnancy-induced hypertension. Arn. J. Obstet. Gynecol. 1990; 162: 362-366.

Walker JJ., Calder AA., Greer I. Treatment of acute pregnancy related hypertension: labetalol and hydralazine compared. Postgrad Med. J. 1983; 59(suppl 3): 168.

Naden RP., Redman CWG. Antihypertensive drugs in pregnancy. Symposium on medical disorders during pregnancy. Clin. Perinatol 1985; 12: 521-538.

Berkowitz R., Coustain D., Mochizuki T. Manual de farmacología en el embarazo. Salvat S.A., Barcelona 1990; 281.

Venkata SR. Hypertensive crisis. En Symposium on cardiovascular emergencies. Cardiol Clin. 1984; 2(2): 211-224.

Rubenstein EB. , Escalan te C. Hypertensive Crisis. Critical Care Clin. 1989; 5(3) : 477-495.

Sibai BM .. Me Cubbin JH., Anderson GD et al. Eclampsia I. Observations from 67 recent cases. Obstet. Gynecol. 1981 ; 58: 609- 613.

Pritchard JA., Cunningham FG., Pritchard SA. The Parkland Memorial Hospital Protocol for treatment of eclampsia: evaluation of 245 cases. Arn. J. Obstet. Gynecol. 1984; 148:951.

Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin. Obstet. Gynecol. 1966; 9: 945.

Barton JR., Sibai BM., Ahokas RA et al. Magnesimn sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am. J. Obstet. Gynecol. 1992; 167: 931- 934.

Young BK., Weinstein HM. Effects of magnesium sulfate on toxemic patients in labor. Obstet. Gynecol. 1977; 49: 681.

Cotton DB., Gonik B., Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Arn. J. Obstet. Gynecol. 1984; 148: 162-165.

Sibai BM. Magnesium sulphate is the ideal anticonvulsivant in preeclampsia-eclampsia. Arn. J. Obstet. Gynecol. 1992; 162(5): 1141-1145.

Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br. J. Obstet. Gynecol. 1990; 97: 104.

Vásquez D., Cardoso B., Plata M., Torres L: Estudio comparativo entre sulfato de magnesio y difenilhidantoína en la preeclampsia grave y eclampsia. Resúmenes XVIII Congreso Nacional de Obstetricia y Ginecología. Barranquilla, diciembre, 1990. En Rev. Col, Obstet. Ginecol. 42S(4): 18.

Benedetti TJ., Kates R., Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am. J. Obstet. Gynecol. 1985; 152: 330-334.

Hou S. Acute and chronic renal failure in pregnancy. En Critical Care Obstetrics, 2nd. Ed, Boston, 1991, Blackwell Scientific Publications, 22: 433.

Sibai BM., Lipshitz J et al. Reassessment of intravenous MgS04 therapy in preeclampsia-eclampsia. Obstet. Gynecol. 1981; 57: 199.

Repke JT. Prevention of preeclampsia. En Hypertension and pregnancy. Clin. Perinatol 18(4): 779-792.

Belizan JM. , Villar J., Repke J. The relationship between calcium intake and pegnancy-induced hypertension; up to date evidence. Arn. J. Obstet. Gynecol. 1988; 158: 898-902.

Kawasaki N., Matsui K., Nakamura T et al. Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. Arn. J. Obstet. Gynecol. 1985; 153: 576-582.

Villar J., Repke J. , Belizan JM et al. Calcium supplementation reduces blood pressure during pregnancy: Results from a randomized clinical trial. Obstet. Gynecol. 1987; 70: 317 322.

Belizan JM., Villar J. , Gonzalez Letal. Calcium supplementation to prevent hypertensive disorders of pregnancy. New. Engl. J. Mee!. 1991 ; 325: 1399-1405.

Frenkel Y., Barkai G., Mashiach S., Dolev E et al. Hypocalciuria of preeclampsia is independient of parathyroid hormone level. Obstet.

Gynecol. 1991 ; 77(5): 689-691.

Brubaker DB., Ross MC., Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am. J. Obstet. Gynecol. 1992; 166: 526-531.

Sanchez- Ramos L., Iones DC., Cullen MT. Urinary calcium as an early marker for preeclampsia. Obstet. Gynecol. 1991; 77: 685.

Clinical and biochemical evidence of endothelial cell dysfunction in pregnancy-induced hypertension (Editorial) Am. J. Hyperten. 1991 ; 4(8): 700-708.

Sibai BM. , Villar MA., Bray E. Magnesium supplementation during pregnancy: A double blind randomized controlled clinical trial. Am. J. Obstet. Gynecol. 1989; 161: 115-119.

Mahomed K., James DK., Golding J et al. Zinc supplementation during pregnancy. A double blind randomized controlled trial. Br.Meel . J. 1989; 299: 826.

Favier A. , Favier M. Effects of zinc deficiency in pregnancy on the mother and the newborn. Rev. Fr. Gynecol. Obstet. 1990; 85(1): 13- 27.

Behne D., Wolters SL. Selenium contentad glutathione peroxidase activity in the plasma and erythrocytes of nonpregnant and pregnant women. J. Clin. Chem. C!in. Biochem 1979; 17: 133-135.

Sibai BM., Mirro R. , Chesney CM et al. Low dose aspirin in pregnancy. Obstet. Gynecol. 1989; 74: 551-557.

Sanchez-Ramos L. , O' Sullivan MJ, Garrido-Calderón J. Effect of low-dose aspirin in angiotensin II pressor response in human pregnancy. Am J. Obstet. Gynecol. 1987; 156: 193- 194.

Walsh SW. Physiology of low-dose aspirin therapy for the prevention of preeclampsia. Sem Perinatol 1990; 14(2): 152-170.

Schiff E., Peleg E., Goldenberg Metal. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of Thromboxane A2 to Prostacyclin in relatively high risk pregnancies. N. Engl. J. Med. 1989; 321: 351 -356.

Brown CE., Gant NF., Cox K et al. Low dose aspirin: U. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. Am. J. Obstet. Gynecol. 1990; 163: 1853-1861

Benigni A., Gregorini G., Frusca T et al. Effect of low-dose aspirin on fetal and maternal generation of Thromboxane by platelets in women at risk for pregnancy-induced hypertension. N. Engl. J. Med. 1989; 321: 357-362.

Walsh SW. Physiology of low-dose aspirin therapy for the prevention of preeclampsia. Sem Perinatol 1990; 14(2): 152-170

Diss EM, Gabbe SG, Moore JW. Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. Am. J. Obstet. Gynecol. 1992; 167: 1046-1052.

Schiff E., Barkai G., Ben-Baruch G et al. Low dose aspirin does not influence the clinical course of woman with mild pregnancy-induced hypertension. Obstet. Gynecol. 1990; 76: 742-744.

Davidge ST., Hubel CA., Brayden RN et al. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet. Gynecol. 1992; 79: 897-901.

Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am. J. Obstet. Gynecol. 1991; 165(1): 1701-1704.